Systemic sclerosis (SSc) or scleroderma is a rare, chronic, autoimmune disorder that hardens connective tissue and muscle in the body. As a result, this can generate complications associated with skin ...

The 35-year-old woman initially presented to a rheumatologist in October 2022 with typical Raynaud's phenomenon affecting her hands. Capillaroscopy revealed a characteristic SSc pattern with decreased ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...

Please provide your email address to receive an email when new articles are posted on . Half of patients with systemic sclerosis demonstrated signs of disordered eating. Patients with SSc often manage ...

Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system mistakenly attacks healthy cells, tissues and ...

Systemic sclerosis (SSc) is a rare autoimmune disease that can harden the skin, impair blood flow, and damage internal organs such as the lungs and kidneys. But no two patients experience the disease ...

Please provide your email address to receive an email when new articles are posted on . More than 30% of patients with systemic sclerosis, mostly with diffuse cutaneous involvement, had an initial ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms. Now, researchers from Japan ...

Systemic sclerosis is a complex autoimmune connective‐tissue disorder characterised by microvascular injury, immune dysregulation and progressive fibrosis of the skin and internal organs. A triad of ...

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell ...

Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived ...

AMSTERDAM — For patients with diffuse cutaneous systemic sclerosis, an autoimmune disease for which there are few treatment options, lenabasum (JBT-101, Corbus Pharmaceuticals) shows potential, new ...